-
1
-
-
0030716498
-
Shattuck lecture-cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
-
Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
-
(1997)
N Engl J Med
, vol.337
, pp. 1360-1369
-
-
Braunwald, E.1
-
2
-
-
0031686381
-
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction
-
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 695-703
-
-
Dries, D.L.1
Exner, D.V.2
Gersh, B.J.3
Domanski, M.J.4
Waclawiw, M.A.5
Stevenson, L.W.6
-
3
-
-
34147115631
-
Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry
-
ALPHA Study Group
-
De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L, Devecchi P, Molon G, Revera M, Curnis A, Sarzi Braga S, Accardi F, Salerno-Uriarte JA, ALPHA Study Group. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007;9:502-509.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 502-509
-
-
De Ferrari, G.M.1
Klersy, C.2
Ferrero, P.3
Fantoni, C.4
Salerno-Uriarte, D.5
Manca, L.6
Devecchi, P.7
Molon, G.8
Revera, M.9
Curnis, A.10
Sarzi Braga, S.11
Accardi, F.12
Salerno-Uriarte, J.A.13
-
4
-
-
35948988073
-
Management of atrial fibrillation in patients with heart failure
-
Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Bohm M. Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568-2577.
-
(2007)
Eur Heart J
, vol.28
, pp. 2568-2577
-
-
Neuberger, H.R.1
Mewis, C.2
Van Veldhuisen, D.J.3
Schotten, U.4
Van Gelder, I.C.5
Allessie, M.A.6
Bohm, M.7
-
5
-
-
73849119887
-
Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics
-
CHAMP Study Investigators
-
Leclercq C, Padeletti L, Cihak R, Ritter P, Milasinovic G, Gras D, Paul V, Van Gelder IC, Stellbrink C, Rieger G, Corbucci G, Albers B, Daubert JC, CHAMP Study Investigators. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace 2010;12:71-77.
-
(2010)
Europace
, vol.12
, pp. 71-77
-
-
Leclercq, C.1
Padeletti, L.2
Cihak, R.3
Ritter, P.4
Milasinovic, G.5
Gras, D.6
Paul, V.7
Van Gelder, I.C.8
Stellbrink, C.9
Rieger, G.10
Corbucci, G.11
Albers, B.12
Daubert, J.C.13
-
6
-
-
76349116026
-
Atrial fibrillation and longterm prognosis in patients hospitalized for heart failure: Results from heart failure survey in Israel (HFSIS)
-
Shotan A, Garty M, Blondhein DS, Meisel SR, Lewis BS, Shochat M, Grossman E, Porath A, Boyko V, Zimlichman R, Caspi A, Gottlieb S. Atrial fibrillation and longterm prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS). Eur Heart J 2010;31:309-317.
-
(2010)
Eur Heart J
, vol.31
, pp. 309-317
-
-
Shotan, A.1
Garty, M.2
Blondhein, D.S.3
Meisel, S.R.4
Lewis, B.S.5
Shochat, M.6
Grossman, E.7
Porath, A.8
Boyko, V.9
Zimlichman, R.10
Caspi, A.11
Gottlieb, S.12
-
7
-
-
0033916120
-
Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure
-
Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21: 1238-1245.
-
(2000)
Eur Heart J
, vol.21
, pp. 1238-1245
-
-
Crijns, H.J.1
Tjeerdsma, G.2
De Kam, P.J.3
Boomsma, F.4
Van Gelder, I.C.5
Van Den Berg, M.P.6
Van Veldhuisen, D.J.7
-
8
-
-
0037635434
-
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study
-
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-2925.
-
(2003)
Circulation
, vol.107
, pp. 2920-2925
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
Vasan, R.S.4
Leip, E.P.5
Wolf, P.A.6
D'Agostino, R.B.7
Murabito, J.M.8
Kannel, W.B.9
Benjamin, E.J.10
-
9
-
-
2942594092
-
Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure
-
Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 2004;6:421-426.
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 421-426
-
-
Ahmed, A.1
Thornton, P.2
Perry, G.J.3
Allman, R.M.4
Delong, J.F.5
-
10
-
-
26044449944
-
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with betablockers: Results from COMET
-
Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M, Metra M, Torp-Pedersen C, Poole-Wilson P. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with betablockers: results from COMET. Eur Heart J 2005;26:1303-1308.
-
(2005)
Eur Heart J
, vol.26
, pp. 1303-1308
-
-
Swedberg, K.1
Olsson, L.G.2
Charlesworth, A.3
Cleland, J.4
Hanrath, P.5
Komajda, M.6
Metra, M.7
Torp-Pedersen, C.8
Poole-Wilson, P.9
-
11
-
-
33646254610
-
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM)
-
CHARM Investigators
-
Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA, CHARM Investigators. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program J Am Coll Cardiol 2006;47:1997-2004.
-
(2006)
Program J Am Coll Cardiol
, vol.47
, pp. 1997-2004
-
-
Olsson, L.G.1
Swedberg, K.2
Ducharme, A.3
Granger, C.B.4
Michelson, E.L.5
McMurray, J.J.6
Puu, M.7
Yusuf, S.8
Pfeffer, M.A.9
-
12
-
-
79955397670
-
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy
-
Smit MD, Maass AH, Hillege HL, Wiesfeld AC, Van Veldhuisen DJ, Van Gelder IC. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy. Eur J Heart Fail 2011;13:543-550.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 543-550
-
-
Smit, M.D.1
Maass, A.H.2
Hillege, H.L.3
Wiesfeld, A.C.4
Van Veldhuisen, D.J.5
Van Gelder, I.C.6
-
13
-
-
53249090182
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ESC Committee for Practice Guidelines Document Reviewers
-
Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Document Reviewers. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442.
-
(2008)
Eur Heart J
, vol.29
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
Stromberg, A.7
Van Veldhuisen, D.J.8
Atar, D.9
Hoes, A.W.10
Keren, A.11
Mebazaa, A.12
Nieminen, M.13
Priori, S.G.14
Swedberg, K.15
Vahanian, A.16
Camm, J.17
De Caterina, R.18
Dean, V.19
Dickstein, K.20
Filippatos, G.21
Funck-Brentano, C.22
Hellemans, I.23
Kristensen, S.D.24
McGregor, K.25
Sechtem, U.26
Silber, S.27
Tendera, M.28
Widimsky, P.29
Zamorano, J.L.30
more..
-
14
-
-
0035853053
-
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial
-
Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001;103: 1428-1433.
-
(2001)
Circulation
, vol.103
, pp. 1428-1433
-
-
Lechat, P.1
Hulot, J.S.2
Escolano, S.3
Mallet, A.4
Leizorovicz, A.5
Werhlen-Grandjean, M.6
Pochmalicki, G.7
Dargie, H.8
-
15
-
-
0034869195
-
Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: Retrospective analysis of the US Carvedilol Heart Failure Trials Program
-
Joglar JA, Acusta AP, Shusterman NH, Ramaswamy K, Kowal RC, Barbera SJ, Hamdan MH, Page RL. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J 2001;142: 498-501.
-
(2001)
Am Heart J
, vol.142
, pp. 498-501
-
-
Joglar, J.A.1
Acusta, A.P.2
Shusterman, N.H.3
Ramaswamy, K.4
Kowal, R.C.5
Barbera, S.J.6
Hamdan, M.H.7
Page, R.L.8
-
16
-
-
33747308395
-
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study
-
van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, Ohlsson L, Wedel H, Wikstrand J. Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study. Eur J Heart Fail 2006;8:539-546.
-
(2006)
Eur J Heart Fail
, vol.8
, pp. 539-546
-
-
Van Veldhuisen, D.J.1
Aass, H.2
El Allaf, D.3
Dunselman, P.H.4
Gullestad, L.5
Halinen, M.6
Kjekshus, J.7
Ohlsson, L.8
Wedel, H.9
Wikstrand, J.10
-
17
-
-
80053244728
-
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction
-
Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011;13:1111-1120.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 1111-1120
-
-
Linssen, G.C.1
Rienstra, M.2
Jaarsma, T.3
Voors, A.A.4
Van Gelder, I.C.5
Hillege, H.L.6
Van Veldhuisen, D.J.7
-
18
-
-
63549126216
-
Heart failure with normal left ventricular ejection fraction: What is the evidence?
-
Kindermann M, Reil JC, Pieske B, van Veldhuisen DJ, Bohm M. Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med 2008;18:280-292.
-
(2008)
Trends Cardiovasc Med
, vol.18
, pp. 280-292
-
-
Kindermann, M.1
Reil, J.C.2
Pieske, B.3
Van Veldhuisen, D.J.4
Bohm, M.5
-
19
-
-
0036829197
-
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) Rationale and design
-
Shibata MC, Flather MD, Bohm M, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Parkhomenko A, Soler-Soler J, Tavazzi L, Toman J, Van Veldhuisen DJ, Coats AJ, Poole-Wilson P; Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design Int J Cardiol 2002; 86:77-85.
-
(2002)
Int J Cardiol
, vol.86
, pp. 77-85
-
-
Shibata, M.C.1
Flather, M.D.2
Bohm, M.3
Borbola, J.4
Cohen-Solal, A.5
Dumitrascu, D.6
Ferrari, R.7
Lechat, P.8
Parkhomenko, A.9
Soler-Soler, J.10
Tavazzi, L.11
Toman, J.12
Van Veldhuisen, D.J.13
Coats, A.J.14
Poole-Wilson, P.15
-
20
-
-
13544258730
-
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
-
SENIORS Investigators
-
Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-225.
-
(2005)
Eur Heart J
, vol.26
, pp. 215-225
-
-
Flather, M.D.1
Shibata, M.C.2
Coats, A.J.3
Van Veldhuisen, D.J.4
Parkhomenko, A.5
Borbola, J.6
Cohen-Solal, A.7
Dumitrascu, D.8
Ferrari, R.9
Lechat, P.10
Soler-Soler, J.11
Tavazzi, L.12
Spinarova, L.13
Toman, J.14
Bohm, M.15
Anker, S.D.16
Thompson, S.G.17
Poole-Wilson, P.A.18
-
21
-
-
66149123458
-
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure)
-
ENIORS Investigators
-
van Veldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009;53:2150-2158.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 2150-2158
-
-
Van Veldhuisen, D.J.1
Cohen-Solal, A.2
Bohm, M.3
Anker, S.D.4
Babalis, D.5
Roughton, M.6
Coats, A.J.7
Poole-Wilson, P.A.8
Flather, M.D.9
-
22
-
-
0025933460
-
Prognostic significance of atrial fibrillation in advanced heart failure A study of 390 patients
-
Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84:40-48.
-
(1991)
Circulation
, vol.84
, pp. 40-48
-
-
Middlekauff, H.R.1
Stevenson, W.G.2
Stevenson, L.W.3
-
23
-
-
0028900436
-
Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly the Cardiovascular Health Study
-
Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995;91:1739-1748.
-
(1995)
Circulation
, vol.91
, pp. 1739-1748
-
-
Gardin, J.M.1
Siscovick, D.2
Anton-Culver, H.3
Lynch, J.C.4
Smith, V.E.5
Klopfenstein, H.S.6
Bommer, W.J.7
Fried, L.8
O'Leary, D.9
Manolio, T.A.10
-
24
-
-
0032972473
-
Prevalence of heart failure and left ventricular dysfunction in the general population: The Rotterdam Study
-
Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. Eur Heart J 1999;20:447-455.
-
(1999)
Eur Heart J
, vol.20
, pp. 447-455
-
-
Mosterd, A.1
Hoes, A.W.2
De Bruyne, M.C.3
Deckers, J.W.4
Linker, D.T.5
Hofman, A.6
Grobbee, D.E.7
-
25
-
-
33747204114
-
RAte Control Efficacy in permanent atrial fibrillation: A comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II
-
Van Gelder IC, van Veldhuisen DJ, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Bosker HA, Cornel JH, Kamp O, Veeger NJ, Volbeda M, Rienstra M, Ranchor AV, TenVergert EM, van den Berg MP. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II. Am Heart J 2006;152:420-426.
-
(2006)
Am Heart J
, vol.152
, pp. 420-426
-
-
Van Gelder, I.C.1
Van Veldhuisen, D.J.2
Crijns, H.J.3
Tuininga, Y.S.4
Tijssen, J.G.5
Alings, A.M.6
Bosker, H.A.7
Cornel, J.H.8
Kamp, O.9
Veeger, N.J.10
Volbeda, M.11
Rienstra, M.12
Ranchor, A.V.13
Tenvergert, E.M.14
Van Den Berg, M.P.15
-
26
-
-
77951033991
-
Lenient versus strict rate control in patients with atrial fibrillation
-
Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, van Veldhuisen DJ, van den Berg MP. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-1373.
-
(2010)
N Engl J Med
, vol.362
, pp. 1363-1373
-
-
Van Gelder, I.C.1
Groenveld, H.F.2
Crijns, H.J.3
Tuininga, Y.S.4
Tijssen, J.G.5
Alings, A.M.6
Hillege, H.L.7
Bergsma-Kadijk, J.A.8
Cornel, J.H.9
Kamp, O.10
Tukkie, R.11
Bosker, H.A.12
Van Veldhuisen, D.J.13
Van Den Berg, M.P.14
-
27
-
-
77951097043
-
Rate control in atrial fibrillation
-
Dorian P. Rate control in atrial fibrillation. N Engl J Med 2010;362:1439-1441.
-
(2010)
N Engl J Med
, vol.362
, pp. 1439-1441
-
-
Dorian, P.1
-
28
-
-
80054758753
-
The effect of rate control on quality of life in patients with permanent atrial fibrillation: Data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study
-
RACE II Investigators
-
Groenveld HF, Crijns HJ, Van den Berg MP, Van Sonderen E, Alings AM, Tijssen JG, Hillege HL, Tuininga YS, Van Veldhuisen DJ, Ranchor AV, Van Gelder IC, RACE II Investigators. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) Study. J Am Coll Cardiol 2011;58: 1795-1803.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1795-1803
-
-
Groenveld, H.F.1
Crijns, H.J.2
Van Den Berg, M.P.3
Van Sonderen, E.4
Alings, A.M.5
Tijssen, J.G.6
Hillege, H.L.7
Tuininga, Y.S.8
Van Veldhuisen, D.J.9
Ranchor, A.V.10
Van Gelder, I.C.11
-
29
-
-
0030589326
-
Effect of an irregular ventricular rhythm on cardiac output
-
Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78:1433-1436.
-
(1996)
Am J Cardiol
, vol.78
, pp. 1433-1436
-
-
Daoud, E.G.1
Weiss, R.2
Bahu, M.3
Knight, B.P.4
Bogun, F.5
Goyal, R.6
Harvey, M.7
Strickberger, S.A.8
Man, K.C.9
Morady, F.10
-
30
-
-
84856203229
-
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: Results of the ELANDD study
-
Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, Vardas PE, Bohm M, Dei Cas L. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail 2012;14:219-225.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 219-225
-
-
Conraads, V.M.1
Metra, M.2
Kamp, O.3
De Keulenaer, G.W.4
Pieske, B.5
Zamorano, J.6
Vardas, P.E.7
Bohm, M.8
Dei Cas, L.9
-
31
-
-
77957738116
-
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
-
European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery ESC Committee for Practice Guidelines Document Reviewers
-
European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Document Reviewers, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlof B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-1420.
-
(2010)
Europace
, vol.12
, pp. 1360-1420
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
Van Gelder, I.C.7
Al-Attar, N.8
Hindricks, G.9
Prendergast, B.10
Heidbuchel, H.11
Alfieri, O.12
Angelini, A.13
Atar, D.14
Colonna, P.15
De Caterina, R.16
De Sutter, J.17
Goette, A.18
Gorenek, B.19
Heldal, M.20
Hohloser, S.H.21
Kolh, P.22
Le Heuzey, J.Y.23
Ponikowski, P.24
Rutten, F.H.25
Vahanian, A.26
Auricchio, A.27
Bax, J.28
Ceconi, C.29
Dean, V.30
Filippatos, G.31
Funck-Brentano, C.32
Hobbs, R.33
Kearney, P.34
McDonagh, T.35
Popescu, B.A.36
Reiner, Z.37
Sechtem, U.38
Sirnes, P.A.39
Tendera, M.40
Vardas, P.E.41
Widimsky, P.42
Vardas, P.E.43
Agladze, V.44
Aliot, E.45
Balabanski, T.46
Blomstrom-Lundqvist, C.47
Capucci, A.48
Crijns, H.49
Dahlof, B.50
Folliguet, T.51
Glikson, M.52
Goethals, M.53
Gulba, D.C.54
Ho, S.Y.55
Klautz, R.J.56
Kose, S.57
McMurray, J.58
Perrone Filardi, P.59
Raatikainen, P.60
Salvador, M.J.61
Schalij, M.J.62
Shpektor, A.63
Sousa, J.64
Stepinska, J.65
Uuetoa, H.66
Zamorano, J.L.67
Zupan, I.68
more..
-
32
-
-
33645406544
-
A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: Effects on clinical profile, neurohormones and survival
-
Rienstra M, Van Gelder IC, van den Berg MP, Boomsma F, Hillege HL, van Veldhuisen DJ. A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival. Int J Cardiol 2006;109:95-100.
-
(2006)
Int J Cardiol
, vol.109
, pp. 95-100
-
-
Rienstra, M.1
Van Gelder, I.C.2
Van Den Berg, M.P.3
Boomsma, F.4
Hillege, H.L.5
Van Veldhuisen, D.J.6
-
33
-
-
53549085406
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
ESC Committee for Practice Guidelines (CPG)
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 933-989
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
Stromberg, A.7
Van Veldhuisen, D.J.8
Atar, D.9
Hoes, A.W.10
Keren, A.11
Mebazaa, A.12
Nieminen, M.13
Priori, S.G.14
Swedberg, K.15
-
34
-
-
33644878739
-
Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
-
Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005;112:3738-3744.
-
(2005)
Circulation
, vol.112
, pp. 3738-3744
-
-
Solomon, S.D.1
Anavekar, N.2
Skali, H.3
McMurray, J.J.4
Swedberg, K.5
Yusuf, S.6
Granger, C.B.7
Michelson, E.L.8
Wang, D.9
Pocock, S.10
Pfeffer, M.A.11
|